Cargando…

Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma

Uterine leiomyosarcoma (uLMS) is the most frequent subtype of uterine sarcoma that presents a poor prognosis, high rates of recurrence, and metastasis. Currently, the molecular mechanism of the origin and development of uLMS is unknown. Class I histone deacetylases (including HDAC1, 2, 3, and 8) are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Qiwei, Falahati, Ali, Khosh, Azad, Mohammed, Hanaa, Kang, Wenjun, Corachán, Ana, Bariani, Maria Victoria, Boyer, Thomas G., Al-Hendy, Ayman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735512/ https://www.ncbi.nlm.nih.gov/pubmed/36497061 http://dx.doi.org/10.3390/cells11233801

Ejemplares similares

The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma
por: Yang, Qiwei, et al.
Publicado: (2022)

The Role of Hedgehog Pathway in Uterine Leiomyosarcoma
por: Garcia, Natalia, et al.
Publicado: (2021)

Understanding the Impact of Uterine Fibroids on Human Endometrium Function
por: Navarro, Antonia, et al.
Publicado: (2021)

The Functional Role and Regulatory Mechanism of FTO m(6)A RNA Demethylase in Human Uterine Leiomyosarcoma
por: Yang, Qiwei, et al.
Publicado: (2023)

Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment
por: Yang, Qiwei, et al.
Publicado: (2021)

Targeting Hedgehog Pathway and DNA Methyltransferases in Uterine Leiomyosarcoma Cells
por: Garcia, Natalia, et al.
Publicado: (2020)

SAT632 The Functional Role And Regulatory Mechanism Of FTO M(6)A RNA Demethylase In Human Uterine Leiomyosarcoma
por: Yang, Qiwei, et al.
Publicado: (2023)

Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model
por: Garcia, Natalia, et al.
Publicado: (2021)

Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature
por: de Almeida, Bruna Cristine, et al.
Publicado: (2022)

Class I histone deacetylases (HDAC1–3) are histone lysine delactylases
por: Moreno-Yruela, Carlos, et al.
Publicado: (2022)

Eloquent silence: developmental functions of Class I histone deacetylases
por: Cunliffe, Vincent T
Publicado: (2008)

Medicinal chemistry advances in targeting class I histone deacetylases
por: Abdallah, Diaaeldin I., et al.
Publicado: (2023)

Class I histone deacetylase complex: Structure and functional correlates
por: Wang, Xiao, et al.
Publicado: (2023)

Roles and Targets of Class I and IIa Histone Deacetylases in Cardiac Hypertrophy
por: Kee, Hae Jin, et al.
Publicado: (2011)

Subcellular Localization of Class I Histone Deacetylases in the Developing Xenopus tectum
por: Guo, Xia, et al.
Publicado: (2016)

Use of class I histone deacetylase inhibitor romidepsin in combination regimens
por: Petrich, Adam, et al.
Publicado: (2016)

Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)
por: Luo, Yuxiang, et al.
Publicado: (2020)

Update on the Role and Regulatory Mechanism of Extracellular Matrix in the Pathogenesis of Uterine Fibroids
por: Yang, Qiwei, et al.
Publicado: (2023)

Uterine Leiomyosarcoma
por: Byar, Katherine L., et al.
Publicado: (2022)

Report of Exosomes Isolated from a Human Uterine Leiomyoma Cell Line and Their Impact on Endometrial Vascular Endothelial Cells
por: Navarro, Antonia, et al.
Publicado: (2022)

Class I and Class II Histone Deacetylases Are Potential Therapeutic Targets for Treating Pancreatic Cancer
por: Wang, Guan, et al.
Publicado: (2012)

The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer
por: Khabele, Dineo
Publicado: (2014)

A distal regulatory region of a class I human histone deacetylase
por: Werbeck, Nicolas D., et al.
Publicado: (2020)

Selective Targeting of Class I Histone Deacetylases in a Model of Human Osteosarcoma
por: Torres, Haydee M., et al.
Publicado: (2021)

Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
por: Schmidt, Oxana, et al.
Publicado: (2021)

Transcriptome analysis identifies the role of Class I histone deacetylase in Alzheimer’s disease
por: Geng, Fan, et al.
Publicado: (2023)

Expression of Class I and Class II a/b Histone Deacetylase is Dysregulated in Hypertensive Animal Models
por: Kee, Hae Jin, et al.
Publicado: (2017)

Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
por: Ecker, Jonas, et al.
Publicado: (2015)

Isoform-specific characterization of class I histone deacetylases and their therapeutic modulation in pulmonary hypertension
por: Chelladurai, Prakash, et al.
Publicado: (2020)

Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
por: Schmidt, Oxana, et al.
Publicado: (2022)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Converting of Myometrial Stem Cells to Tumor-Initiating Cells: Mechanism of Uterine Fibroid Development
por: Yang, Qiwei, et al.
Publicado: (2016)

Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
por: Fritzsche, Florian R, et al.
Publicado: (2008)

Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy
por: Shen, Li, et al.
Publicado: (2012)

Reversal of epigenetic promoter silencing in Friedreich ataxia by a class I histone deacetylase inhibitor
por: Chutake, Yogesh K., et al.
Publicado: (2016)

Peptide‐Based 2‐Aminophenylamide Probes for Targeting Endogenous Class I Histone Deacetylase Complexes
por: Seidel, Julian, et al.
Publicado: (2019)

Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer
por: McCaw, Tyler R., et al.
Publicado: (2020)

Reduction of class I histone deacetylases ameliorates ER‐mitochondria cross‐talk in Alzheimer's disease
por: Marinho, Daniela, et al.
Publicado: (2023)

Myometrial progesterone hyper-responsiveness associated with increased risk of human uterine fibroids
por: Omar, Mona, et al.
Publicado: (2019)

Transcription Regulation by Class III Histone Deacetylases (HDACs)—Sirtuins
por: Dai, Yan, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8rs0icd92u6lvp5l3sq0g98948